Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-12-22

Clinical Trial Update: Study to Investigate the Efficacy and Pharmacokinetic Profile of K-877-ER Compared to K-877-IR [Phase 2]

View source ↗

Summary

Phase 2 trial comparing extended-release K-877-ER to immediate-release K-877-IR in dyslipidemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • K-877-ER (pemafibrate)
  • K-877-IR

Snippet

Sponsor: Kowa Research Institute, Inc. | Conditions: Dyslipidemia | Phase 2 | Status: COMPLETED | Results posted: 2023-12-22